Skip to content

SmartSense4Life - Configurable electronics platform for individualized rehabilitation after stroke and spinal cord injury

SmartSense4Life - Configurable electronics platform for individualized rehabilitation after stroke and spinal cord injury - SmartSense4Life_SCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032591
Enrollment
3
Registered
2023-09-01
Start date
2023-08-31
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G82.3 G82.4 G82.5

Interventions

Group 1: The target group for this study comprises individuals with cervical spinal cord injury. In this context, the onset of paralysis should be at least 2 months ago. These individuals exhibit impa

Sponsors

Universitätsklinikum Heidelberg - Klinik für Paraplegiologie - Sektion Experimentelle Neurorehabilitation
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • People with cervical spinal cord injury (SCI), at least 2 months after SCI, with weak or absent hand or grasp function • Age over 18 • Sufficient preserved voluntary shoulder movements and elbow flexion on at least one, ideally the dominant side of the body • Capacity to provide informed consent

Exclusion criteria

Exclusion criteria: • Significant limitations of passive joint mobility (contractures) of arms and hands (>30% of physiological range of motion) • Excessive spasticity in the arms • Skin disorders on the arms (inflammations/infections, psoriasis, eczema, burns, etc.) • Hyperesthetic areas on the arms (upper and lower arm) preventing achieving sufficient muscle contraction strength • Presence of a pacemaker or other active implants, such as (medication) pumps or diaphragm pacemakers • Metal implants in the direct flow area of the stimulation electrodes • Lesions of the brachial plexus with consequent paresis or other diseases or injuries leading to significant denervation of arm and hand muscles (FES stimulation only possible in innervated muscles!) • Known seizure disorder (epilepsy) • Higher cognitive impairments or psychiatric disorders that would limit the application of the neuroprosthesis • Pregnancy • Febrile infections

Design outcomes

Primary

MeasureTime frame
The main objective of the study is to evaluate the functionality of and the user satifaction with the SmartSense4Life system.

Secondary

MeasureTime frame
The secondary goal of the study is to examine and assess the user-friendliness and ergonomics of the system. The focus here is on capturing user experience in terms of intuitive usability and optimal ergonomic features.

Countries

Germany

Contacts

Public ContactRüdiger Rupp

Universitätsklinikum Heidelberg - Klinik für Paraplegiologie - Sektion Experimentelle Neurorehabilitation

ruediger.rupp@med.uni-heidelberg.de+49(0)6221/562-9230

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026